Microorganisms produce a variety of secondary metabolites with interesting structural features and biological activities as we can not imagine. Someof them have occupied a weighty position as medicines and agricultural drugs and for animal health. Recent progress of isolation and purification techniques and apparatus such as NMR spectroscopy in addition to establishment of new screening methods for bioactive microbial metabolites have resulted in discovery of novel biologically active compounds1*. Biosynthetic studies on secondary metabolites using compoundsenriched with 1 3C and other stable isotopic atoms followed by NMRspectroscopic analyses provided us not only biosynthetic information of the carbon skeleton but also enzymatic and stereochemical 717 aspects for a C-C bond formation and its reconstruction.
Especially, the labeling patterns of 13C enriched compounds to polyketide skeletons which are typified by polycyclic aromatic and macrocyclic compounds, branchedchain fatty acid lactone, and their complexes inform us the regularity in C-C bond formation2~4). Furthermore, it suggests that the biosynthetic findings deduced from the feeding experiments of 13C atom and its NMR spectrometry would be useful means for the structure elucidation of novel compounds5). Particularly, the approach of the enzymatic function in each condensation step in the chain-elongation process and molecular genetics to polyketide biosynthesis will occupy a dominant position in production of new compounds.
Present article is reviewed in centering around our hitherto biosynthetic studies on bioactive compounds, including the biosynthesis and stereochemistry of clinically useful macrolide antibiotics and the production of new hybrid macrolides by microbial conversion and of a novel polyketide by gene manupilation.
I. Biosynthesis of Bioactive Compounds from Microorganisms
During past 25 years, Omura and his coworkers6'7) have found manynovel compoundswith a variety of biological activities from microorganisms by introducing and constructing effective screening systems. Some of new compoundspossess unique structural skeleton deriving from pathways via polyketide, shikimate, followed by condensation with segments from amino acid and or mevalonate pathways. In this item, biosynthetic pathways and its mechanismsinvolving a unique formation, cleavage, rearrangement ofC-C bond and their enzymatic reactions, in addition to biosynthetic origin for the carbon skeleton via metabolic pathway consisting of lower organic acids, isoprenoid, shikimate, amino acids and their complex are described in exemplifying some of bioactive compounds, hitachimycin, okilactomycin, setomimycin, furaquinocin, vineomycin, asukamycin, reductiomycin, purpactin A, lactacystin, and pyripyropene. A. Hitachimycin Hitachimycin8'9) is an antiprotozoal antibiotic isolated from the culture broth of actinomycete strain No. KM 4927. A novel 19-membered ring lactam skeleton for hitachimycin is substantially distinguishable with ansamycin antibiotics10) in the point that the antibiotic contains no aromatic or quinoid nucleus in the ansachain moiety. The labeling pattern by [I-13C] acetate of hitachimycin molecule indicated that the antibiotic consists of eight malonates, one methylmalonate and one phenylalanine11}, as illustrated in Fig. 1 . A high level of enrichment at C-19 in the feeding experiment of Although tyrosine aminomutase has been reported in the biosynthesis of a peptide antibiotic, edeine12), the occurrence of phenylalanine aminomutase in a hitachimycinproducing strain may be the first finding in microbial secondary metabolites. vealed that the carbon skeleton of okilactomycin is built up from four acetates, four propionates, one methionine, and three carbons at C-12, C-13, and C-14, as shown in Fig. 2 . In general, it seems to be a commonobservation that occurence of C-methyl group on a polyketide chain in actinomycetes is derived biosynthetically from methyl ofpropionate, rather than from methionine. In this point, occurrence of the methyl group at C-l l deriving from methionine seems to be a rare case in a biosynthetic pattern of metabolites from actinomycetes. The biosynthetic origin of the remaining three carbons was deduced from the feeding experiment of 75%enriched
The observation of the 13C-13C
coupling pattern among C-13, C-14 and C-15 implies that the unit arises from an intact glycerol unit derived via glucose15). This finding suggests that the C3 unit in tetrocarcin A aglycone which contains a structurally similar unit as okilactomycin is also derived from glycerol as a precursor16).
is an antibacterial and antitumor antibiotic which was isolated from the cultured broth of Streptomyces pseudovenezuelae. The structure of the antibiotic was determined to -be a unique substituted 9,9'-bianthryl skeleton by means of various 13C NMR Fig. 3 . The site of decarboxylation in the nonaketide was. evidenced from the appearance of two enriched singlet signals assignable to the methyl groups (C-12 and C-12') of acetate unit in the NMRspectrum of [1 ,2-13C2] quinone chromophoreand an isoprenoid-like side chain from the structural feature. The feeding of [1,2-13C2 for biosynthetic process on polyacetate elongation of the chromophore of both aglycones. As a plausible formation mechanism for the aglycones, it was thought that the chromophore of component Ax would be formed first and then converted to that of B2 by ring opening from the following labeling pattern of 13C labeled acetate to the chromophore. The feeding experiment of [l,2-13C2] acetate to B2 appeared 16 carbon signals flanked by satellite signals due to the 13C-13Csplitting and the singlet signals assignable to the remaining three carbons, C-l , C-3' , and C-4' . Appearance of each singlet signal means cleavages at least two C-C bonds of acetate units during the formation of the chromophore of B2. Since the C-4' signal was enriched, whereas those at C-l and C-3' were not from the feeding experiment of [I-13C]acetate, it was concluded that C-l and C-3' are derived from the C-2 carbon of acetate. This means that both carbons at C-l and C-4' originated from the sameacetate molecule via pathwayof a simple decaacetate for B2. Therefore, the chromophore of B2 would be derived from that of Ax by the cleavage between C-l2b and C-l in A1 via pathway A. Furthermore, the appearance of at least two 13C-13C coupling pairs, i.e., between C-5 and C-6 and between C-ll and C-lla suggests that the mode of elongation of the decaacetate is the same as that of B2. The site of decarboxylation was determined to be at C-2, because of appearance of only one enriched singlet signal for C-2. Vineomycin biosynthesis is confident to give the useful information for the structural characteristics of novel isotetracenone antibiotics such as kerriamycins25) and urdamycins26)
which possess a methyl group at C-3 position and an functional group of oxygen atom at C-l, C-7, C-8 and C-1 2 deriving biosynthetically from an oxygen of acetate. larly anticoccidial activity in chickens. The structural and biosynthetic interestings are intensed to a central structural element a multifunctional m-C7N unit which consists of a six-membered ring carrying one carbon and one nitrogen atom in a meta disposition and C5N unit (2-amino-3-hydroxycyclopent-2-enone) .
The m-C7N unit is most commonly quininoid as exemplified by rifamycin29), pactamycin30), geldanamycin3 1), and ansamitocin32). The biosynthesis of the m-C7N unit in these antibiotics have been demonstrated to proceed by a branch of the shikimate pathway, with 3-amino-5-hydroxybenzoic acid (AHBA) or 3-aminobenzoic acid (ABA) as proximate precursors33). The feeding experiment of AHBAand ABAwhich are potential precursors labeled with 13C in the carboxyl group in addition to feeding of [1-13C] experiments were conducted with 1 3C precursors such as acetate, succinate and glycerol34), as shown in Fig. 6 . The feeding of sodium [I-13C] acetate clearly enriched positions C-6 and C-7 in the m-C7Nunit, suggestive of a "tail-to-tail". This arrangement was evidenced from is facilitated by formation of an a-carbanion equivalent, possibly through the intermediacy of a Schiff base with a pyridoxal phosphate co factor, as shown in Fig. 8 . Reductiomycin consists of two structural units, C5N unit which is found in asukamycin molecule and an acetoxydihydrofuran unit bearing an acrylic acid side chain, as shown in Fig. 9 . The biosynthetic origin of the C5N unit was unequivocally proven by feeding of [4,5-1 3C2] aminolevulinic acid, as described in asukamycin biosynthesis45).
Regarding to the carbon source of the dihydrofuranylacrylic acid moiety, it was thought that the entire-nine carbon assembly, including the acetoxyl group, could be derived by a ring cleavage of phenylalanine or tyrosine, followed indicated that 4-hydroxybenzoate or a closely related product, e.g., the corresponding aldehyde must be the substrate for the ring cleavage reaction leading to the formation of the dihydrofuran moiety. The hypothetical pathway and the formation mechanism of the dihydrofuranylacrylic moiety have been proposed by analyzing the incorporation pattern of 4-hydroxybenzoic acid and its aldehyde labeled with 13C and deuterium46).
H. Purpactin
Purpactins47 '48) were found from the culture broth of Penicillium purpurogenum FO-608 as an inhibitor of acyl-CoA: cholesterol acyltransferase (ACAT) by an assay using rat liver microsomes as enzyme source. Purpactins are the first microbial ACAT inhibitors.
Purpactin A which possesses a tricyclic skeleton and mevalonate moiety is structurally similar to penicillide from Penicillium, but the detailed biosynthetic pathway had not been clarified. Each feeding experiment of [1-13C] and [2-13C] Thus, purpactin B is the first isogrisan compoundderived from a single octaketide chain and is nonenzymatically converted to purpactin A.
I. Lactacystin
Lactacystin51'52), a novel compound which induces differentiation of Neuro2a cells, a mouseneuroblastoma cell line, possesses a unique y-lactam skeleton containing hydroxyisobutyl and cysteinylthioester moieties. Three units consisting of L-leucine, L-cysteine and isobutyrate were speculated as its precursor for the carbon skeleton coupling between C-10 and C-ll and between C-4 and C-5, respectively, and singlet peaks for C-9 and C-12.
This corresponds to the spectral pattern of the precursor, L-leucine; it clearly demonstrates that no racemization at C-10 has occurred in the formation of this segment from leucine. The retention of the configuration at C-10 during the formation of lactacystin was proved by
Therefore, diastereotopic methyl groups, C-l l and C-12
are assignable as/?roR and/?ro-S, respectively53'54). Such feeding experiments in general are valuable means to understand the biosynthesis of secondary metabolites containing valine and leucine moieties. fold, suggesting that nicotinic acid was incorporated as a precursor to the molecule. This speculation was confirmed by the incorporation of [14C]nicotinic acid followed by degradation of 14C-labeled pyripyropene by
Jones' oxidation and then treatment of CH3ONa to nicotinic acid. This is the first finding that an intact nicotinic acid works as an acyl primer unit for oligoketide formation in fungal secondary metabolites58). For the biosynthesis of pyripyropene A, the following steps are proposed: 1) the pyridino-a-pyrone moiety is produced via condensation of a primer nicotinic acid with two acetates in a "head to tail" fashion, 2) an all farnesyl pyrophosphate is formed from three mevalonates, 3) the two parts are linked and cyclized to form the core skeleton, 4) then three acetyl residues from acetates are introduced into the skeleton to build up pyripyropene A.
II. Structure Elucidation on Polyketide
Antibiotics by Biosynthetic Means A polyketide skeleton in second microbial metabolites consists of an assembly of acetate, malonate, methylmalonate, a methyl of methionine, and lower molecular organic acids such as succinate and butyrate. Especially, biosynthetic findings on typical polyketides such as tetracyclines, macrolides and polyethers from actinomycetes have provided us that the carbon skeletons are built up via each step of a condensation and chain elongation with a definite regularity. This implies that an incorporation pattern of 13Cenriched precursors would be useful means for not only the assignment of biosynthetic origin of the carbon skeleton, but also structure elucidation by NMRassignment for the C-C connectivity of polyketide skeleton5*. The structure elucidation of polyketides by biosynthetic means using irumamycin enriched with [1,2-13C2] acetate and [1,2-1 3C2] propionate exhibited additional satellites based on intermolecular and intramolecular 1 3C-13C coupling for each of the carbon signals which appeared as doublet. The 13C-13Cdecoupling experiments of these satellite peaks deduced a 20-membered macrocyclic structure containing a 6-membered ring hemiketal. Appearance of a long range 13C-13C coupling (3/cc= ll.3Hz) between C-24 and C-26 of ethyl ketone supported the exsistence of a,/?-epoxy-a',/?'-ethyl ketone moiety in irumamycin.
The proposed structure was also evidenced from the structural feature of an ozonolysis products of diacetylirumamycin. In general, the carbon skeleton of polyketides produced by actinomycetes originates from malonate (and/or acetate) as the biosynthetic origin for C2 unit and methylmalonate (and/or propionate) for C3 unit in polyketide chain. On the other hand, fungal polyketides add extra carbons from the methyl group of methionine. This is especially evident when the labeling patterns of fungal metabolite such as phomenoicacid67) which is produced by Phoma lingam are compared with those of irumamycin, as illustrated in Fig. 16 .
During the biosynthetic studies of irumamycin, its aglycones, irumanolides I and II were found from a mutant of an irumamycin-producing strain obtained by NTG treatment68). Both aglycones were microbially converted to irumamycin under the presence of a polyketide biosynthetic inhibitor, cerulenin69) during the fermentation of the parent strain. This implies that both aglycones are converted to irumamycinvia an epoxidation and glycosidation.
D. Phthoramycin
In the course of screening program for cellulose biosynthesis inhibitor, phthoramycin70) was found in the An extremely high incorporation of sodium [1- 13C]isocaproate into C-1 5 implies that isocaproate is intact precursor. Although there are somereports that partially elaborate polyketides (C6 and C8 fatty acids) were incorporated into polyketides molecule73), it seems to be the first finding in the biosynthesis of microbial metabolites that isocaproate was incorporated as an intact precursor into the middle position on the polyketide chain. ADEQUATE spectrum permitted derivation of partial structures (A), (B) and (C), as depicted in Fig. 18 . The C-Cconnectivity amongpartial structures was evidenced from the NMRanalysis of dihydroaurantinin B obtained by NaBH4reduction of aurantinin B and a dimethyl ester of the dicarboxylic acid derivative obtained by alkaline hydrolysis followed by methylation with diazomethane. The feeding of L-[ 1 3C-methyl]methionine revealed a high level of incorporation for five methyl carbons (C-32, C-35, C-36, C-37 and C-38). The location of the methyl groups in the polyketide chain is reasonably assigned by appearance of a doublet signal for each carbon atom attached directly to five 13C-enriched methyl carbons. Thus, aurantinin B75) possesses a novel structure involving an acid anhydride moiety and a novel sugar, in addition to a conjugated polyketide skeleton consisting of four rings. Aurantinin seems to be formed biosynthetically from two polyketide chains. A long chain originates from eleven acetate units, three C1 units arising from methionine, two Cx units at C-5 and C-7 from an acetate via decarboxylation and one Cx unit at C-l from an acetate via demethylation. A short chain consists of and B2 were assigned by NMRanalyses including NOE measurements and studying the mechanism of inter- conversion on heat treatment among components85).
Xanthoquinodins are the first heterodimers of octaketidederived xanthone and anthraquinone monomersconnected in an "end-to-body". that glycolate metabolized from glycerol may be a direct precursor for the C2 unit.
Similarly, it has been clarified that the aglycon moiety of tylosin derives from two acetate units, five propionate units, and one butyrate unit, as shown in Fig. 23 . An interesting thing is a high level of incorporation by the feeding of [1-13C] butyrate not only at C-5 but also at carbons, 3, 7, ll, 13, and 15 which should be derived from the carboxyl carbon of propionate. This labeling pattern indicates obviously that butyrate are metabolized into propionyl-CoA or methylmalonyl-CoA via succinate involving an oxidation and isomerization97). Further, the feeding experiment of [l,3,r-13C3]2-ethylmalonic acid showed an additional enrichment at carbons, 3, 4, ll, 12, 13, 14, 15 , and 16 accompanied with a doublet signal arising from 1 3C-13C coupling, in addition to enrichment at carbons 5 and 19, indicating the metabolic pathway of [l,3,r-13C3]2-ethylmalonate to methylmalonate via methylmalonyl-CoA mutase, as shown in Fig. 23 . Thus, macrolide biosynthesis gave us that trace experiment of 13C atom by feeding of 13C enriched compounds are useful tools to knowthe existence of newmetabolic pathwaysof lower organic acids in microorganism. which is an aglycone oftylosin. As a results, no significant enrichments or 13C-13C couplings could be detected by 13C NMR,indicating that the precursor had most likely been degradated to a mixture of [1-13C] and [2-1 3C] propionate during incorporation into the macrolides. However, the conversion of above (2,S,3jR)-[2,3-1 3C2]-2-methyl-3-hydroxypentanoic acid into the corresponding 7V-acetylcysteamine (NAC) thioester recognized the enrichment of carbon signals and coupled doublets at C-12 and C-13 in erythromycin B, as shown in Fig. 24 from fermentation broth assume particular significance in light of the important discoveries in molecular genetics regarding to the organization of the polyketide synthase responsible for individual steps of polyketide chain elongation and functional group modification.
C. Biosynthesis of 16-Membered Macrolides after the Formation of the Lactone Ring
After the formation of the aglycone skeleton, the biosynthetic sequence for macrolide antibiotics was investigated by introduction of two methods using a blocked mutant and microbial transformation using cerulenin69 production and increased expression of macrocin Omethyltransferase which catalyzes the terminal conversion of macrocin to tylosin in manyof the mutants. proposed to be R and S, respectively, as illustrated in Fig. 30 . Comparative NMRand CDanalyses of tylosin and the derivatives with the aglycone derived from leucomycin A3 whose absolute configuration has been determined by X-ray crystallographic analysis115) revealed the 3R, 4S, 5S, 6R and 8#-configurations for tylosin. However, the configurations at C-14 and C-15 of tylosin have not been specified. For configurational assignment of all asymmetric centers of tylosin, a biosynthetic intermediate, protylonolide assigned by X-ray crystallographic analysis1 1651 17) was transformed microbially to tylosin under the inhibition of the production of tylosin aglycone in the presence of cerulenin. Retention with the configuration of the protylonolide during the microbial transformation to tylosin was evidenced from comparative CD analysis between protylonolide and 5-0-mycaminosylprotylonolide which was derived from the transformed tylosin. As a result, the configuration for the aglycone moiety oftylosin was assigned to be 3R,AS, 5S, 6R, 8R, 14S and 15R1 17\ Therefore, 1^-configuration of tylosin proposed by Celmer was revised to be 14S. After that, the stereochemistry of 16-memberedmacrolides such as rosaramicin1 18), acumycin119), and mycinamicin120) which possess an asymmetric center at C-14 was confirmed to possess 14iS-configuration by X-ray crystallographic analysis. Furthermore, it has been clarified that an antibiotic, M-4365 G121) also possesses the same configuration with the aglycone of tylosin from the microbial transformation of protylonolide to M-4365 Gx with retention of the configuration122).
E. Production of Hybrid Macrolides by Microbial Transformation
The isolation of aglycone from a mutant may serve not only for the biosynthetic studies described above, but also as a starting material for the construction of new macrolide antibiotics. Maezawaet al.123) has applied to the production of new macrolide by a microbial glycosidation of narbonolide which is an aglycone of a 14-membered macrolide, narbomycin, with mycaminose finding in only 16-membered macrolides. 5-0-Mycaminosyl-narbonolide was obtained successfully by the feeding experiments of narbonolide to the fermentation broth of a platenomycin-producing strain. Attempt of the glycosidation of platenolide with desosamine involving in only 14-membered macrolides affords also a new hybrid macrolide, 5-(9-desosaminyl platenolide124), as shown in Fig. 31 . Both new hybrid macrolides possess antibacterial activity against Gram-positive bacteria. Omura et al.125 ) attempted the microbial production of new hybrid macrolides using a biosynthetic inhibitor of polyketide, cerulenin. By means of so called "hybrid biosynthesis", the biologically inactive tylosin aglycone was converted into novel antibacterial macrolide, chimeramycin by a spiramycin-producing strain Sm.
ambofaciens KA-448 in the presence of cerulenin. Novel hybrid macrolides, chimeramycins A and B, in which spiramycin constituted sugars, mycaminosyl-mycarose and forosamine were bonded glycosidically at C-5, and C-9 of protylonolide, respectively, were successfully produced by the method, as shown in Fig. 32 to each biosynthetic step on the cloned DNAfragment had been also determined135). Then, it was tried to introduce the whole or a part of fragments of actinorhodin biosynthetic genes into other Streptomyces strains which produced actinorhodin-related antibiotics. Since most of Streptomyces strains possessed the restriction system, it was difficult to introduce recombinant plasmids, however, transformants were obtained from two kinds of strains, kalafungin producer Streptomyces tanashiensis including whole genes for actinorhdin biosynthesis did not produce mederrhodins, however, produced actinorhodin and medermycin. The biosynthesis and productivity of mederrhodins by transformants were relatively high and quite stable. All recombinant plasmids (PIJ 2301 (PIJ , 2315 (PIJ and 2316 contained the transcriptional unit of act V and the inserted DNAfragment would be mentioned as follow: 1) medermycin was synthesized by biosynthetic genes of Streptomyces sp. AM7161. 2) the hydroxyl residue was substituted at C-6 position of the naphthoquinone skeleton by hydroxylase which is a gene product of an inserted DNAfragment (act V) of PIJ 2315. Antimicrobial activity of mederrhodin A was similar to that of medermycin. In a future, knowledges from the breeding of the mederrhodin's producer will give manyinformations to molecular breeding of other antibiotic-producing organisms. 
